DME Capital Management’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-4,177
Closed -$283K – 62
2021
Q3
$283K Sell
4,177
-10,109
-71% -$740K 0.02% 48
2021
Q2
$1.1M Buy
+14,286
New +$870K 0.07% 51

Other funds holding DMK

DME Capital Management's DMK Position: Q4 2021 in Review

DME Capital Management sold out of DMK Pharmaceuticals (DMK) in Q4 2021, closing a stake of 4,177 shares — an estimated $283K sold.

DME Capital Management first reported a position in DMK in Q2 2021 and held it in 2 quarters. The position peaked at $1.1M in Q2 2021. 49 funds tracked by Wall St. Rank hold DMK as of Q4 2021.

  • DME Capital Management reported no remaining DMK Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • DME Capital Management sold 4,177 DMK Pharmaceuticals shares in Q4 2021, an estimated $283K.
  • DME Capital Management first reported a position in DMK Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • DME Capital Management's DMK Pharmaceuticals position peaked at $1.1M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q4 2021.

Based on DME Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.